MELD-XI Score (for Advanced Heart Failure, Pre-Transplant)

Clinical calculation support · Verify results before clinical use

Clinical calculator

Enter the most recent laboratory values.

— MELD-XI
Values below 1.0 mg/dL are treated as 1.0 mg/dL for this calculation.
Values below 1.0 mg/dL are treated as 1.0 mg/dL; values above 4.0 mg/dL are capped at 4.0 mg/dL under the referenced MELD conventions.
Reset

About MELD-XI

MELD-XI (Model for End-Stage Liver Disease excluding INR) combines total bilirubin and serum creatinine to estimate hepatic and renal dysfunction. In advanced heart failure, it has been studied as a marker associated with outcomes before and after mechanical circulatory support or heart transplantation.

Formula

MELD-XI = 5.11 × ln(bilirubin) + 11.76 × ln(creatinine) + 9.44

Both laboratory values are expressed in mg/dL. For the MELD conventions referenced here, bilirubin and creatinine have a lower limit of 1.0 mg/dL, creatinine is capped at 4.0 mg/dL, and creatinine is set to 4.0 mg/dL for patients receiving dialysis.

Interpreting the result

The score is continuous; the same cutoff should not be assumed to apply to every clinical setting. The score bands shown by this calculator (<14, 14 to <17, and ≥17) preserve the original tool’s categories for orientation, but they are not universal thresholds for transplant candidacy or individual mortality prediction. Studies have used different groupings according to population and outcome.

Clinical considerations

  • Interpret the score alongside clinical status, congestion, trends in laboratory results, anticoagulation context, comorbidities, and the full transplant or mechanical-support assessment.
  • A single score does not determine transplant eligibility and should not replace specialist assessment.
  • The formula was originally derived for short-term mortality assessment in cirrhosis; its use in advanced heart failure is supported by subsequent disease-specific studies, which should be considered when selecting thresholds.

References

Heuman DM, Mihas AA, Habib A, et al. MELD-XI: a rational approach to “sickest first” liver transplantation in cirrhotic patients requiring anticoagulant therapy. Liver Transpl. 2007;13(1):30–37. Formula source; originally developed in a liver-transplant population. DOI: 10.1002/lt.20906; PMID: 17154400.
Kim MS, Kato TS, Farr M, et al. Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction. J Am Coll Cardiol. 2013;61(22):2253–2261. Study of MELD-based scores in ambulatory heart failure and heart-transplant evaluation. DOI: 10.1016/j.jacc.2012.12.056; PMID: 23563127.
Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support. Retrospective VAD cohort study using MELD-XI and a threshold of ≥17 versus <17. J Heart Lung Transplant. 2012. DOI: 10.1016/j.healun.2012.02.027; PMID: 22458997.
MELD-XI Score Predicts Early Mortality in Patients After Heart Transplantation. UNOS cohort study of 22,597 adult heart-transplant recipients; derived cohort quartiles (low ≤10.5, low-intermediate 10.6–12.6, intermediate-high 12.7–16.4, high >16.4), demonstrating that cutoffs vary by study. PMID: 26387720.